Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Shimura, Hideki, Hattori, Nobutaka, Kubo, Shin-ichiro, Mizuno, Yoshikuni, Asakawa, Shuichi, Minoshima, Shinsei, Shimizu, Nobuyoshi, Iwai, Kazuhiro +3 more·2000·Nature Genetics

Cited by (1,004)

Items 301–400 of 1,004

  1. Effect of Wild-type or Mutant Parkin on Oxidative Damage, Nitric Oxide, Antioxidant Defenses, and the Proteasome
    Hyun, Dong-Hoon, Lee, MoonHee, Hattori, Nobutaka, Kubo, Shin-Ichiro, Mizuno, Yoshikuni, Halliwell, Barry, Jenner, Peter · 2002 · Journal of Biological Chemistry
  2. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications
    Qian Huang, Maria E. Figueiredo‐Pereira · 2010 · APOPTOSIS
  3. Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition
    María Teresa Ibarra-Gutiérrez, Norma Serrano‐García, Marisol Orozco‐Ibarra · 2023 · Molecular Neurobiology
  4. A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system
    van Wijk, Sjoerd J L, de Vries, Sjoerd J, Kemmeren, Patrick, Huang, Anding, Boelens, Rolf, Bonvin, Alexandre M J J, Timmers, H Th Marc · 2009 · Molecular Systems Biology
  5. The genetics of Parkinson disease: implications for neurological care
    Christine Klein, Michael G. Schlossmacher · 2006 · Nature Clinical Practice Neurology
  6. The ubiquitin system: pathogenesis of human diseases and drug targeting
    Aaron J. Ciechanover, Alan L. Schwartz · 2004 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  7. Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy
    Dong Chen, Feng Gao, Bin Li, Hongfeng Wang, Yuxia Xu, Cuiqing Zhu, Guanghui Wang · 2010 · Journal of Biological Chemistry
  8. Update on the genetics of Parkinson's disease
    Thomas Gasser · 2007 · Movement Disorders
  9. Parkin and PINK1 functions in oxidative stress and neurodegeneration
    Sandeep Kumar Barodia, Rose B. Creed, Matthew S. Goldberg · 2016 · Brain Research Bulletin
  10. p62/ SQSTM1 and Selective Autophagy in Cardiometabolic Diseases
    Se‐Jin Jeong, Xiangyu Zhang, Astrid Rodríguez-Vélez, Trent D. Evans, Babak Razani · 2018 · Antioxidants and Redox Signaling
  11. Targeting mitophagy in neurodegenerative diseases
    Odetta Antico, Paul W. Thompson, Nicholas T. Hertz, Miratul M. K. Muqit, Laura E. Parton · 2025 · Nature Reviews Drug Discovery
  12. Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells
    Emiliano Biasini, Luana Fioriti, Ilaria Ceglia, Roberto William Invernizzi, Alessandro Bertoli, Roberto Chiesa, Gianluigi Forloni · 2003 · Journal of Neurochemistry
  13. Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1
    Andreas Weihofen, Beth L. Ostaszewski, Yasufumi Minami, Dennis J. Selkoe · 2007 · Human Molecular Genetics
  14. Milestones in PD genetics
    Thomas Gasser, John Hardy, Yoshikuni Mizuno · 2011 · Movement Disorders
  15. Reciprocal Roles of Tom7 and OMA1 during Mitochondrial Import and Activation of PINK1
    Shiori Sekine, Chunxin Wang, Dionisia P. Sideris, Eric N. Bunker, Zhe Zhang, Richard J. Youle · 2019 · Molecular Cell
  16. The AMPK–Parkin axis negatively regulates necroptosis and tumorigenesis by inhibiting the necrosome
    Seung Baek Lee, Jung Jin Kim, Sang‐Ah Han, Yingfang Fan, Li-Sha Guo, Khaled Aziz, Somaira Nowsheen, Sung Sun Kim, Seon‐Young Park, Qifeng Luo et al. · 2019 · Nature Cell Biology
  17. Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease
    Kevin St. P. McNaught, C. Warren Olanow · 2005 · Neurobiology of Aging
  18. Structural and Functional Insights to Ubiquitin-Like Protein Conjugation
    Frederick C. Streich, Christopher D. Lima · 2014 · Annual Review of Biophysics
  19. Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation
    Fanjun Meng, Dongdong Yao, Yang Shi, Jonathan Kabakoff, Wei Wu, Joshua Jay Reicher, Yuliang Ma, Bernd Moosmann, Eliezer Masliah, Stuart A. Lipton et al. · 2011 · Molecular Neurodegeneration
  20. Associations Among -TrCP, an E3 Ubiquitin Ligase Receptor, -Catenin, and NF- B in Colorectal Cancer
    Andrei V. Ougolkov, B. Zhang, K. Yamashita, Vladimir N. Bilim, M Mai, Serge Yu. Fuchs, Toshinari Minamoto · 2004 · JNCI Journal of the National Cancer Institute
  21. Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse
    Rita Perfeito, Teresa Cunha‐Oliveira, Ana Cristina Rego · 2013 · Free Radical Biology and Medicine
  22. Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease
    Hui‐Ming Gao, Jau‐Shyong Hong · 2011 · Progress in Neurobiology
  23. Update on Parkinson Disease
    Andrew D. Siderowf, Matthew Stern · 2003 · Annals of Internal Medicine
  24. miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1)
    Kim, Jaekwang, Fiesel, Fabienne C., Belmonte, Krystal C., Hudec, Roman, Wang, Wang-Xia, Kim, Chaeyoung, Nelson, Peter T., Springer, Wolfdieter, Kim, Jungsu · 2016 · Molecular Neurodegeneration
  25. Novel mutation in the TOR1A (DYT1) gene in atypical, early onset dystonia and polymorphisms in dystonia and early onset parkinsonism
    Joanne Leung, Christine Klein, Jennifer Friedman, P. Vieregge, Helfried Jacobs, Dana O. Doheny, Christoph Kamm, Deborah DeLeon, Peter Paul Pramstaller, John B. Penney et al. · 2001 · Neurogenetics
  26. Pathogenetic mechanisms of parkin in Parkinson's disease
    Nobutaka Hattori, Yoshikuni Mizuno · 2004 · The Lancet
  27. Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila
    Ho Yin Edwin Chan · 2002 · Human Molecular Genetics
  28. RING finger 1 mutations in Parkin produce altered localization of the protein
    Mark Cookson · 2003 · Human Molecular Genetics
  29. Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study
    Naheed L. Khan · 2002 · Brain
  30. Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function
    Magali Periquet, Olga Corti, Sandrine Jacquier, Alexis Brice · 2005 · Journal of Neurochemistry
  31. Mitochondrial Dysfunction in Parkinson's Disease
    Jianhui Zhu, Charleen T. Chu · 2010 · Journal of Alzheimer s Disease
  32. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants
    Kaori Nishikawa, Hang Li, Ryoichi Kawamura, Hitoshi Osaka, Yu-Lai Wang, Yoko Hara, Takatsugu Hirokawa, Yoshimasa Manago, Taiju Amano, Mami Noda et al. · 2003 · Biochemical and Biophysical Research Communications
  33. Parkin and the Molecular Pathways of Parkinson's Disease
    Benoit I. Giasson, Virginia M.‐Y. Lee · 2001 · Neuron
  34. Increased Oxidative Stress Exacerbates α-Synuclein Aggregation In Vivo
    Owen Scudamore, Thomas Ciossek · 2018 · Journal of Neuropathology & Experimental Neurology
  35. Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease
    Ari Barzilai, Eldad Melamed · 2003 · Trends in Molecular Medicine
  36. Inhibitory effects of pesticides on proteasome activity: Implication in Parkinson's disease
    Xuefeng Wang, Sharon Li, Arthur P. Chou, Jeff M. Bronstein · 2006 · Neurobiology of Disease
  37. Genetic basis of Parkinson's disease: inheritance, penetrance, and expression
    Thomas Gasser · 2011 · The Application of Clinical Genetics
  38. The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats
    Mao, Zhijuan, Liu, Chanchan, Ji, Suqiong, Yang, Qingmei, Ye, Hongxiang, Han, Haiyan, Xue, Zheng · 2017 · Neurochemical Research
  39. Parkinson's disease and cancer: two wars, one front
    Michael J. Devine, Hélène Plun‐Favreau, Nicholas William Wood · 2011 · Nature reviews. Cancer
  40. Parkin Sensitizes toward Apoptosis Induced by Mitochondrial Depolarization through Promoting Degradation of Mcl-1
    Richard G. Carroll, Émilie Hollville, Séamus J. Martin · 2014 · Cell Reports
  41. Protective effect against Parkinson's disease-related insults through the activation of XBP1
    Megumi Sado, Yuki Yamasaki, Tomoyuki Iwanaga, Yasushi Onaka, Tatsuki Ibuki, Shigeki Nishihara, Hiroshi Mizuguchi, Hiroshi Momota, Ryuichi Kishibuchi, Tetsuya Hashimoto et al. · 2008 · Brain Research
  42. Evaluation of 50 probands with early-onset Parkinson’s disease for Parkin mutations
    Katja Hedrich, Karen S. Marder, Juliette M. Harris, M. Kann, Timothy Lynch, Helen Meija‐Santana, Peter Paul Pramstaller, EBERHARD SCHWINGER, Susan Bressman, Stanley Fahn et al. · 2002 · Neurology
  43. The BAL-binding Protein BBAP and Related Deltex Family Members Exhibit Ubiquitin-Protein Isopeptide Ligase Activity
    Kunihiko Takeyama, Ricardo C.T. Aguiar, Liqun Gu, Chunyan He, Gordon James Freeman, Jeffery Lorne Kutok, Jon Christopher Aster, Margaret Ann Shipp · 2003 · Journal of Biological Chemistry
  44. Redox Reactions Induced by Nitrosative Stress Mediate Protein Misfolding and Mitochondrial Dysfunction in Neurodegenerative Diseases
    Zezong Gu, Tomohiro Nakamura, Stuart A. Lipton · 2010 · Molecular Neurobiology
  45. Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain and neurodegeneration
    Martin Balaštík, Francesco Ferraguti, André Pires‐daSilva, Tae Ho Lee, Gonzalo Álvarez-Bolado, Kun Ping Lu, Peter Gruß · 2008 · Proceedings of the National Academy of Sciences
  46. Association of the Cytoskeletal GTP-binding Protein Sept4/H5 with Cytoplasmic Inclusions Found in Parkinson's Disease and Other Synucleinopathies
    Masafumi Ihara, Hidekazu Tomimoto, Hitoshi Kitayama, Yoko Morioka, Ichiro Akiguchi, H. Shibasaki, Makoto Noda, Makoto Kinoshita · 2003 · Journal of Biological Chemistry
  47. The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism
    Katja Hedrich · 2001 · Human Molecular Genetics
  48. Parkin and mitochondrial quality control: toward assembling the puzzle
    Konstanze F. Winklhofer · 2014 · Trends in Cell Biology
  49. GBA-Associated Parkinson’s Disease and Other Synucleinopathies
    Ziv Gan‐Or, Christopher Liong, Roy N. Alcalay · 2018 · Current Neurology and Neuroscience Reports
  50. Role of the ubiquitin proteasome system in Parkinson's disease
    Kah‐Leong Lim, Jeanne MM Tan · 2007 · BMC Biochemistry
  51. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease
    Adam J. Harrington, Shusei Hamamichi, Guy A. Caldwell, Kim A. Caldwell · 2010 · Developmental Dynamics
  52. A Drosophila Model of Mutant Human Parkin-Induced Toxicity Demonstrates Selective Loss of Dopaminergic Neurons and Dependence on Cellular Dopamine
    Tzu‐Kang Sang, Hui-Yun Chang, George M. Lawless, Anuradha Ratnaparkhi, Lisa Mee, Larry C. Ackerson, Nigel T. Maidment, David E. Krantz, George R. Jackson · 2007 · Journal of Neuroscience
  53. Hsp70 Gene Transfer by Adeno-associated Virus Inhibits MPTP-Induced Nigrostriatal Degeneration in the Mouse Model of Parkinson Disease
    Zhizhong Dong, David Paul Wolfer, Hans‐Peter Lipp, Hansruedi Büeler · 2004 · Molecular Therapy
  54. Pael‐R is accumulated in Lewy bodies of Parkinson's disease
    Tetsuro Murakami, Mikio Shoji, Yuzuru Imai, Haruhisa Inoue, Takeshi Kawarabayashi, Etsuro Matsubara, Yasuo Harigaya, Atsushi Sasaki, Ryōsuke Takahashi, Koji Abe · 2004 · Annals of Neurology
  55. Functional ATPase Activity of p97/Valosin-containing Protein (VCP) Is Required for the Quality Control of Endoplasmic Reticulum in Neuronally Differentiated Mammalian PC12 Cells
    Taeko Kobayashi, Keiko Tanaka, Kiyoshi Inoue, Akira Kakizuka · 2002 · Journal of Biological Chemistry
  56. Disruption of Protein Quality Control in Parkinson's Disease
    Casey N. Cook, Caroline T. Stetler, Leonard Petrucelli · 2012 · Cold Spring Harbor Perspectives in Medicine
  57. Mitochondrial Contribution to Parkinson's Disease Pathogenesis
    Anthony H.V. Schapira, Matthew E. Gegg · 2011 · Parkinson s Disease
  58. RBR E3‐ligases at work
    Judith J. Smit, Titia K. Sixma · 2014 · EMBO Reports
  59. Genome Patterns of Selection and Introgression of Haplotypes in Natural Populations of the House Mouse (Mus musculus)
    Fabian Staubach, Anna Lorenc, Philipp W. Messer, Kun Tang, Dmitri A. Petrov, Diethard Tautz · 2012 · PLoS Genetics
  60. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer’s disease, Parkinson’s disease
    Sean Hong Tan, Venkatanaidu Karri, Nicole Wuen Rong Tay, Kuan Hui Chang, Hui Yen Ah, Phui Qi Ng, Hui San Ho, Hsiao Wai Keh, Mayuren Candasamy · 2019 · Biomedicine & Pharmacotherapy
  61. Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins
    Dong‐Hoon Hyun, MoonHee Lee, Barry B. Halliwell, Peter G. Jenner · 2003 · Journal of Neurochemistry
  62. The Machado–Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability
    Thomas M. Durcan, Maria Kontogiannea, Thorhildur Thorarinsdottir, Lara Fallon, Aislinn Joanmarie Williams, Ana Djarmati, Tadeu A. Fantaneanu, Henry Lauris Paulson, Edward A. Fon · 2010 · Human Molecular Genetics
  63. Parkin-mediated lysine 63-linked polyubiquitination: A link to protein inclusions formation in Parkinson's and other conformational diseases?
    Kah‐Leong Lim, Valina Lynn Dawson, Ted M. Dawson · 2005 · Neurobiology of Aging
  64. Parkin Accumulation in Aggresomes Due to Proteasome Impairment
    Eunsung Junn, Sang Seop Lee, Unsun T. Suhr, M. Maral Mouradian · 2002 · Journal of Biological Chemistry
  65. A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease
    Donald E. Spratt, R.J. Martinez-Torres, Yeong Ju Noh, Pascal Mercier, Noah Manczyk, Kathryn R. Barber, Jacob D. Aguirre, Lynn Burchell, Andrew G. Purkiss, Helen Walden et al. · 2013 · Nature Communications
  66. What causes cell death in Parkinson's disease?
    Amitabh Gupta, Valina Lynn Dawson, Ted M. Dawson · 2009 · Annals of Neurology
  67. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson’s disease: possible implications of glial cells
    Toshiharu Nagatsu, Makoto Sawada · 2006 · Springer eBooks
  68. RING-Between-RING E3 Ligases: Emerging Themes amid the Variations
    Katja K. Dove, Rachel E. Klevit · 2017 · Journal of Molecular Biology
  69. Inactivation of Parkin by Oxidative Stress and C-terminal Truncations
    Konstanze F. Winklhofer, Iris H. Henn, Penelope C. Kay-Jackson, Ulrich Heller, Jörg Tatzelt · 2003 · Journal of Biological Chemistry
  70. Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity
    Ashok N. Hegde · 2004 · Progress in Neurobiology
  71. Identification of a Novel Zn2+-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E3 Ligase Parkin
    Ventzislava A. Hristova, Steven Beasley, Rebecca Jane Rylett, Gary S. Shaw · 2009 · Journal of Biological Chemistry
  72. Elevated Neuronal Expression of CD200 Protects Wlds Mice from Inflammation-Mediated Neurodegeneration
    Tanuja Chitnis, Jaime Imitola, Yue Wang, Wassim Elyaman, Prianka Chawla, Maia Sharuk, Khadir Raddassi, Roderick Terry Bronson, Samia Joseph Khoury · 2007 · American Journal Of Pathology
  73. Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle
    Kristen A. Malkus, Elpida Tsika, Harry Ischiropoulos · 2009 · Molecular Neurodegeneration
  74. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH‐SY5Y cells
    Masayo Shamoto‐Nagai, Wakako Maruyama, Yoji Kato, Ken‐ichi Isobe, Masashi Tanaka, Makoto Naoi, Toshihiko Osawa · 2003 · Journal of Neuroscience Research
  75. The PINK1–Parkin axis: An Overview
    Keiji Tanaka · 2020 · Neuroscience Research
  76. Mitochondrial dynamics in Parkinson's disease
    Victor S. Van Laar, Sarah Berman · 2009 · Experimental Neurology
  77. Genetics of parkinsonism
    Katrina A. Gwinn · 2002 · Movement Disorders
  78. Parkinson's disease: piecing together a genetic jigsaw
    Marieke Cornelia Johanna Dekker · 2003 · Brain
  79. Role of parkin mutations in 111 community‐based patients with early‐onset parkinsonism
    Martin Kann, Helfried Jacobs, K. Mohrmann, Kirsten Schumacher, Katja Hedrich, Jennifer Garrels, Karin Wiegers, EBERHARD SCHWINGER, Peter Paul Pramstaller, Xandra O. Breakefield et al. · 2002 · Annals of Neurology
  80. A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease
    Peter Holmans, Valentina Moskvina, Lesley Jones, Manu Sharma, Alexey Vedernikov, Finja Büchel, Mohamad Sadd, José Brás, Francesco Bettella, Nayia Nicolaou et al. · 2012 · Human Molecular Genetics
  81. Phosphorylation of Parkin at Serine65 is essential for activation: elaboration of a Miro1 substrate-based assay of Parkin E3 ligase activity
    Agne Kazlauskaite, Van C. Kelly, Clare Johnson, Carla Baillie, C. James Hastie, Mark W. Peggie, Thomas Macartney, Helen I. Woodroof, Dario R. Alessi, Patrick G. A. Pedrioli et al. · 2014 · Open Biology
  82. Back to the tubule: microtubule dynamics in Parkinson’s disease
    Laura Pellegrini, Andrea Wetzel, Simone Grannò, George Heaton, Kirsten Harvey · 2016 · Cellular and Molecular Life Sciences
  83. Parkin Ubiquitinates Tar-DNA Binding Protein-43 (TDP-43) and Promotes Its Cytosolic Accumulation via Interaction with Histone Deacetylase 6 (HDAC6)
    Michaeline L. Hebron, Irina Lonskaya, Kaydee Sharpe, Puwakdandawe P.K. Weerasinghe, Norah Khaled Algarzae, Ashot R. Shekoyan, Charbel Moussa · 2012 · Journal of Biological Chemistry
  84. SH3 Domains from a Subset of BAR Proteins Define a Ubl-Binding Domain and Implicate Parkin in Synaptic Ubiquitination
    Jean‐François Trempe, Carol X.‐Q. Chen, Karl Grenier, Edna Matta‐Camacho, Guennadi Kozlov, Peter Scottt McPherson, Kalle Gehring, Edward A. Fon · 2009 · Molecular Cell
  85. Mitochondrial quality control in acute ischemic stroke
    Hong An, Bing Zhou, Xunming Ji · 2021 · Journal of Cerebral Blood Flow & Metabolism
  86. Ubiquitination of α-Synuclein Is Not Required for Formation of Pathological Inclusions in α-Synucleinopathies
    Deepak M. Sampathu, Benoit I. Giasson, Aaron C. Pawlyk, John Q. Trojanowski, Virginia M.‐Y. Lee · 2003 · American Journal Of Pathology
  87. Review: Familial Parkinson's disease – genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease
    Carola Schiesling, Nicole Kieper, Kay Seidel, Rejko Krüger · 2008 · Neuropathology and Applied Neurobiology
  88. Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson?s disease
    Vincenzo Bonifati, Ben A. Oostra, Peter Heutink · 2004 · Journal of Molecular Medicine
  89. Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process
    Amin Karimi Moghadam, Saeid Charsouei, Benjamin Bell, Mohammad Reza Jabalameli · 2018 · Cellular and Molecular Neurobiology
  90. Spongiform Neurodegeneration-associated E3 Ligase Mahogunin Ubiquitylates TSG101 and Regulates Endosomal Trafficking
    Bong Yoon Kim, James A. Olzmann, Gregory S. Barsh, Lih‐Shen Chin, Lian Li · 2007 · Molecular Biology of the Cell
  91. Ubiquitin pathways in neurodegenerative disease
    Graham Atkin, Henry Lauris Paulson · 2014 · Frontiers in Molecular Neuroscience
  92. M itochondrial DNA and primary mitochondrial dysfunction in P arkinson's disease
    Maria Pia Giannoccaro, Chiara La Morgia, Giovanni Rizzo, Valério Carelli · 2017 · Movement Disorders
  93. Parkin is associated with cellular vesicles
    Shinichiro Kubo, Toshiaki Kitami, Setsuko Noda, Hideki Shimura, Yasuo Uchiyama, Shuichi Asakawa, Shinsei Minoshima, Nobuyoshi Shimizu, Yoshikuni Mizuno, Nobutaka Hattori · 2001 · Journal of Neurochemistry
  94. Spongiform Degeneration in mahoganoid Mutant Mice
    Lin He, Xin‐Yun Lu, Aaron F. Jolly, Adam G. Eldridge, Stanley J. Watson, Peter K. Jackson, Gregory S. Barsh, Teresa M. Gunn · 2003 · Science
  95. Parkin-mediated Monoubiquitination of the PDZ Protein PICK1 Regulates the Activity of Acid-sensing Ion Channels
    Monica Joch, Ariel R. Ase, Carol X.‐Q. Chen, Penny A. MacDonald, Maria Kontogiannea, Amadou Tidjane Corera, Alexis Brice, Philippe Séguéla, Edward A. Fon · 2007 · Molecular Biology of the Cell
  96. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease
    Tito Calí, Denis Ottolini, Marisa Brini · 2011 · BioFactors
  97. Mechanistic Approaches to Parkinson's Disease Pathogenesis
    Ranjita S. Betarbet, Todd Sherer, Donato A. Di Monte, J. Timothy Greenamyre · 2002 · Brain Pathology
  98. Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection
    Jean‐François Trempe, Edward A. Fon · 2013 · Frontiers in Neurology
  99. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration
    Salehi, Ahmad, Delcroix, Jean-Dominique, Mobley, William C. · 2003 · Trends in Neurosciences
  100. How does parkin ligate ubiquitin to Parkinson's disease?
    Philipp J. Kahle, Christian Haass · 2004 · EMBO Reports